Evidence map›Paper›PMID 26500734›Full record

ArticleRare tumors2015

Peritoneal Malignant Mesothelioma with Epithelioid Type, Demonstrating High Serum and Ascitic KL-6 Levels: Immunohistochemical Analyses.

Saifun Nahar, Manabu Nakamoto, Akira Hokama, Chiharu Kobashigawa, Masatoshi Kaida, Tetsu Kinjo, Tetsuo Hirata, Nagisa Kinjo, Masanao Saio, Naoki Yoshimi and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Rare tumors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Saifun NaharDepartment of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus , Nishihnara, Japan.
Manabu NakamotoDepartment of Endoscopy, University of the Ryukyus , Nishihnara, Japan.
Akira HokamaDepartment of Endoscopy, University of the Ryukyus , Nishihnara, Japan.
Chiharu KobashigawaDepartment of Endoscopy, University of the Ryukyus , Nishihnara, Japan.
Masatoshi KaidaDepartment of Endoscopy, University of the Ryukyus , Nishihnara, Japan.
Tetsu KinjoDepartment of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus , Nishihnara, Japan.
Tetsuo HirataDepartment of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus , Nishihnara, Japan.
Nagisa KinjoDepartment of Endoscopy, University of the Ryukyus , Nishihnara, Japan.
Masanao SaioDepartment of Pathology and Oncology, University of the Ryukyus , Nishihnara, Japan.
Naoki YoshimiDepartment of Pathology and Oncology, University of the Ryukyus , Nishihnara, Japan.
Yuji OhtsukiDivision of Pathology, Matsuyama-shimin Hospital , Japan.
Jiro FujitaDepartment of Infectious, Respiratory, and Digestive Medicine, University of the Ryukyus , Nishihnara, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of KL-6 producing peritoneal malignant mesothelioma. A 56-year-old woman was referred to our hospital on November 2005 with severe abdominal distention. Peritoneal malignant mesothelioma with epithelioid type was diagnosed by clinical symptoms, laboratory investigations, imaging studies, and immunohistochemical examination of known tumor markers. In addition, high serum and ascitic KL-6 levels were observed and the immunostaining of the tumor for KL-6 was evident. We thus consider KL-6 to be a potential novel marker for peritoneal malignant mesothelioma with epithelioid type.

Indexed as

KL-6Malignant mesotheliomaperitoneum

Identifiers

PMID26500734
PMCPMC4600996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.